These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19765854)

  • 1. Cannabinoids and experimental models of multiple sclerosis.
    Kubajewska I; Constantinescu CS
    Immunobiology; 2010 Aug; 215(8):647-57. PubMed ID: 19765854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective agents: cannabinoids.
    Sánchez AJ; García-Merino A
    Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.
    Berrendero F; Sánchez A; Cabranes A; Puerta C; Ramos JA; García-Merino A; Fernández-Ruiz J
    Synapse; 2001 Sep; 41(3):195-202. PubMed ID: 11391780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
    Witting A; Chen L; Cudaback E; Straiker A; Walter L; Rickman B; Möller T; Brosnan C; Stella N
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6362-7. PubMed ID: 16571660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.
    Orian JM; D'Souza CS; Kocovski P; Krippner G; Hale MW; Wang X; Peter K
    Front Immunol; 2021; 12():620963. PubMed ID: 33679764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
    Klaren RE; Motl RW; Woods JA; Miller SD
    J Neuroimmunol; 2014 Sep; 274(1-2):14-9. PubMed ID: 24999244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE).
    Bolton C; Smith PA
    Ageing Res Rev; 2018 Jan; 41():64-81. PubMed ID: 29101043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity.
    Yi W; Schlüter D; Wang X
    Brain Behav Immun; 2019 Aug; 80():10-24. PubMed ID: 31125711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of Immune Cell Autophagy in Multiple Sclerosis: Russian Roulette or Silver Bullet?
    Yang G; Van Kaer L
    Front Immunol; 2021; 12():724108. PubMed ID: 34531871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
    Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Brambilla R
    Acta Neuropathol; 2019 May; 137(5):757-783. PubMed ID: 30847559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
    Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.
    Van Kaer L; Postoak JL; Wang C; Yang G; Wu L
    Cell Mol Immunol; 2019 Jun; 16(6):531-539. PubMed ID: 30874627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12 in control of neuroinflammation.
    Momcilović M; Mostarica-Stojković M; Miljković D
    Immunol Res; 2012 Apr; 52(1-2):53-63. PubMed ID: 22392052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.